Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease

NCT00657514 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Insufficient enrollment

Conditions

Peripheral Arterial Disease
Angina

Interventions

DRUG: Ranolazine
DRUG: Placebo

Sponsor

Colorado Prevention Center